BMC Medical Research Methodology (Jan 2024)

Predicting lung cancer survival prognosis based on the conditional survival bayesian network

  • Lu Zhong,
  • Fan Yang,
  • Shanshan Sun,
  • Lijie Wang,
  • Hong Yu,
  • Xiushan Nie,
  • Ailing Liu,
  • Ning Xu,
  • Lanfang Zhang,
  • Mingjuan Zhang,
  • Yue Qi,
  • Huaijun Ji,
  • Guiyuan Liu,
  • Huan Zhao,
  • Yinan Jiang,
  • Jingyi Li,
  • Chengcun Song,
  • Xin Yu,
  • Liu Yang,
  • Jinchao Yu,
  • Hu Feng,
  • Xiaolei Guo,
  • Fujun Yang,
  • Fuzhong Xue

DOI
https://doi.org/10.1186/s12874-023-02043-y
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Lung cancer is a leading cause of cancer deaths and imposes an enormous economic burden on patients. It is important to develop an accurate risk assessment model to determine the appropriate treatment for patients after an initial lung cancer diagnosis. The Cox proportional hazards model is mainly employed in survival analysis. However, real-world medical data are usually incomplete, posing a great challenge to the application of this model. Commonly used imputation methods cannot achieve sufficient accuracy when data are missing, so we investigated novel methods for the development of clinical prediction models. In this article, we present a novel model for survival prediction in missing scenarios. We collected data from 5,240 patients diagnosed with lung cancer at the Weihai Municipal Hospital, China. Then, we applied a joint model that combined a BN and a Cox model to predict mortality risk in individual patients with lung cancer. The established prognostic model achieved good predictive performance in discrimination and calibration. We showed that combining the BN with the Cox proportional hazards model is highly beneficial and provides a more efficient tool for risk prediction.

Keywords